Hospital General de Agudos JM Ramos Mejia

Buenos Aires C1221ADC

0 studies enrolling now · 8 studies all time

What they study most

COVID, Covid19, Focal Onset Seizures, Gaucher Disease, Type 1, HIV Infection, Influenza, Influenza and Other Novel Respiratory Viruses, Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Pre-Exposure Prophylaxis of HIV Infection, Primary Generalized Tonic-Clonic Seizures, SARS-CoV2 Infection

Studies at this site

• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
• Outpatient Treatment With Anti-Coronavirus Immunoglobulin — Paused
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures — Completed
• Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection — Running, not enrolling
• Respiratory Virus Hospitalization Study (FLU 003 Plus) — Completed
• Strategic Timing of Antiretroviral Treatment — Completed
• Respiratory Virus Outpatient Study (FLU 002 Plus) — Completed
• A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE) — Completed